DelveInsights Prader-Willi Syndrome Market Insights, Epidemiology, and Market Forecast 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Prader-Willi Syndrome Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).
The Prader-Willi Syndrome market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Prader-Willi Syndrome: An Overview
According to US National Library of Medicine, Prader-Willi syndrome is a complex genetic condition that affects many parts of the body. In infancy, this condition is characterized by weak muscle tone (hypotonia), feeding difficulties, poor growth, and delayed development. Beginning in childhood, affected individuals develop an insatiable appetite, which leads to chronic overeating (hyperphagia) and obesity.
Although considered a rare disorder, PWS is one of the most common conditions seen in genetic clinics and is the most common genetic cause of obesity that has been identified to date.
Prader-Willi Syndrome Market Key Facts
As per Foundation for Prader-Willi Syndrome (PWS) Research, the disease occurs in approximately one out of every 15,000 births
It affects males and females with equal frequency and affects all races and ethnicities.
The estimates place the incidence between 1 in 10,000-30,000 individuals in the general population, while as per Adult Prader-Willi Syndrome: An Update on Management by Luk Ho-Ming, the incidence is about 1 in 15,00025,000 live births.
According to DelveInsights estimation, the total prevalent cases of Prader Willi syndrome (PWS) were found to be approx. 47,000 in the 7 Major Markets in the year 2017.
Prader-Willi Syndrome Market
The Prader-Willi Syndrome Market Size is expected to experience a positive shift during the study period owing to the launch of upcoming therapies. The therapies under development are focused on novel approaches that will improve the disease condition.
The market outlook section of the report helps to build a detailed comprehension of the historical, current and forecasted Prader-Willi Syndrome market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Prader-Willi Syndrome market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Prader-Willi Syndrome Epidemiology
The epidemiology section covers insights into the historical and current Prader-Willi Syndrome patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Prader-Willi Syndrome Epidemiology Subtype Segmentation
Prevalent cases of Prader Willi Syndrome
Diagnosed cases of PWS
Prader Willi Syndrome (PWS) cases by Mutation types
Prader Willi Syndrome (PWS) associated clinical Manifestation
Prader-Willi Syndrome Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Prader-Willi Syndrome market or expected to get launched in the market during the study period. The analysis covers Prader-Willi Syndrome market uptake by drugs, patient uptake by therapies, and sales of each drug.
Reports Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs based on market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Prader-Willi Syndrome Pipeline Development Activities and provides valuable insights about different therapeutic candidates in various stages and the key companies in the market involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Request for Sample PDF Report https://www.delveinsight.com/sample-request/prader-willi-syndrome-market
Prader-Willi Syndrome Therapeutics Analysis
Currently, there is no cure for PWS. The lives of individuals with PWS can be improved with an early diagnosis and careful management of symptoms but more effective therapies are needed. The treatment of PWS is currently based on treating the symptoms of the disorder as they arise. Growth hormone deficiency is present in almost all children and many adults with PWS. In multiple studies, human growth hormone (HGH) has been found to be beneficial for those with Prader-Willi syndrome.
Some of the key companies in the Prader-Willi Syndrome Market include:
Millendo Therapeutics
Levo Therapeutics
Harmony Biosciences
Soleno Therapeutics
And many more.
Prader-Willi Syndrome Therapies covered in the report include:
And many more.
Get More Detailed Insights Into the Emerging Therapies & Key Companies https://www.delveinsight.com/sample-request/prader-willi-syndrome-market
Table of Content (TOC)
1. Key Insights
2. Executive Summary
3. Prader-Willi Syndrome Competitive Intelligence Analysis
4. Prader-Willi Syndrome Market Overview at a Glance
5. Prader-Willi Syndrome Disease Background and Overview
6. Prader-Willi Syndrome Patient Journey
7. Prader-Willi Syndrome Epidemiology and Patient Population
8. Prader-Willi Syndrome Treatment Algorithm, Current Treatment, and Medical Practices
9. Prader-Willi Syndrome Unmet Needs
10. Key Endpoints of Prader-Willi Syndrome Treatment
11. Prader-Willi Syndrome Marketed Products
12. Prader-Willi Syndrome Emerging Therapies
13. Prader-Willi Syndrome Seven Major Market Analysis
14. Attribute Analysis
15. Prader-Willi Syndrome Market Outlook (7 major markets)
16. Prader-Willi Syndrome Access and Reimbursement Overview
17. KOL Views on the Prader-Willi Syndrome Market.
18. Prader-Willi Syndrome Market Drivers
19. Prader-Willi Syndrome Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.
Download Sample PDF Report https://www.delveinsight.com/sample-request/prader-willi-syndrome-market
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Other Latest Reports By DelveInsight
Metrorrhagia Market
DelveInsights Metrorrhagia Market report delivers an in-depth understanding of the historical and forecasted epidemiology, the Metrorrhagia market size and shares analysis in the 7MM (i.e the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan) as well as the emerging therapies and key companies in the therapeutic domain.
Media ContactCompany Name: DelveInsight Business ResearchContact Person: Shruti ThakurEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432City: Las VegasState: NVCountry: United StatesWebsite: https://www.delveinsight.com/
See the original post:
- We all need HGH, the hormone responsible for growth. What exactly does it do? - USA TODAY - December 23rd, 2024
- What is HGH? And who needs prescription growth hormone - USA TODAY - December 23rd, 2024
- Heartland Group Holdings (NZSE:HGH) investors are sitting on a loss of 47% if they invested three years ago - Yahoo Finance - December 23rd, 2024
- Human Growth Hormone (HGH): Functions, Deficiency, and Treatment - December 11th, 2024
- Firefighters contribute $6,000 to HGH and food banks - The Review Newspaper - November 14th, 2024
- Rockland Knights of Columbus donate $5,000 to the HGH Foundation - The Review Newspaper - November 5th, 2024
- 3 Ways to Increase HGH - wikiHow Health - September 29th, 2024
- The Uncharted Territory of HGH - Sports Illustrated - September 29th, 2024
- Heartland Group Holdings (NZSE:HGH) Is Paying Out Less In Dividends Than Last Year - Simply Wall St - September 5th, 2024
- Legion gives $6,500 to HGH Foundation - The Review Newspaper - September 5th, 2024
- Human Growth Hormone (HGH): How to Boost It and Illegal Use - Insider - December 21st, 2023
- HGH - Overview: Growth Hormone, Serum - Mayo Clinic Laboratories - November 28th, 2023
- HGH, Human Growth Hormones. Your #1 online source for HGH, Muscle, Anti ... - May 15th, 2023
- FDA approves weekly therapy for adult growth hormone deficiency - February 21st, 2023
- Everything to Know About Human Growth Hormone | Muscle & Fitness - January 28th, 2023
- Andy Pettitte's 2007 take on PED use: "I tried HGH. Though it was not against baseball rules, I was not comfortable with what I was doing" -... - December 8th, 2022
- New HGH CEO and Chair discuss staff shortages and other health care challenges - The Review Newspaper - December 8th, 2022
- How can people increase HGH? - Medical News Today - November 30th, 2022
- "I've been accused of something I'm not guilty of.... I've never taken steroids or HGH - When MLB legend Roger Clemens vehemently refuted claims... - November 21st, 2022
- Megan Thee Stallion Puts Health Admin Degree To The Test In Hot Girl Hospital On SNL - HollywoodLife - October 17th, 2022
- Does intermittent fasting work? The Varsity - Varsity - October 9th, 2022
- Super-fit Dana White hits back at douche over steroid accusations - BJPENN.COM - October 9th, 2022
- The Leg Press Vs. the Squat Who Wins the Battle for Leg Day? - BarBend - September 30th, 2022
- Grand Forks instructor is 'Teacher of the Year' - Prairie Public Broadcasting - September 22nd, 2022
- Hindus of Greater Houston honors 75 youth for commitment to community - newsindiatimes.com - September 22nd, 2022
- Discover the Mental and Physical Health Benefits of Fasting - Intelligent Living - September 6th, 2022
- Should You Be Adding Heartland Group Holdings (NZSE:HGH) To Your Watchlist Today? - Simply Wall St - August 29th, 2022
- WBC, ANZ, HGH: How are these top banking stocks faring on NZX? - Kalkine Media - August 29th, 2022
- Here are 5 tips that can help you get a good night's sleep - Firstpost - August 21st, 2022
- Narrative Always Follows Price in the Markets - A Wealth of Common Sense - August 21st, 2022
- Human Growth Hormone (hGH) - Cleveland Clinic - August 13th, 2022
- Control of non-REM sleep by ventrolateral medulla glutamatergic neurons projecting to the preoptic area - Nature.com - August 13th, 2022
- The Rush: Aaron Judges 45th HR puts him on pace to join ranks of all-time greats - Yahoo Sports - August 13th, 2022
- Infrared Search And Track (IRST) System Market Size to Grow by USD 879.44 million, ASELSAN AS and HGH Systemes Infrarouges SAS Among Key Vendors -... - August 5th, 2022
- The 40th Anniversary edition of the HGH Foundations Golf Classic raises more than $55,000 for the hospital - The Review Newspaper - July 28th, 2022
- Industrial Infrared Camera Market Current Development Explored with Leading Players Thermoteknix, HGH, Siemens, Syn-Fab This Is Ardee - This Is... - July 28th, 2022
- The Fastest Way to Look Younger, According to Science Eat This Not That - Eat This, Not That - July 28th, 2022
- Eddie Hearn claims Jarrell Miller owes him money from ill-fated Anthony Joshua fight - The Mirror - July 28th, 2022
- Fauci Lied About Locking Down, We Have the Receipts - The Clay Travis & Buck Sexton Show - July 28th, 2022
- Bring your empties to The Beer Store in Hawkesbury to support HGH Foundation - The Review Newspaper - July 20th, 2022
- Exhibitors report 30% higher biz at HGH India - The Hans India - July 20th, 2022
- Overview Panoramic Thermal Imaging Cameras Market 2022-2028 Business Analysis by Top Companies like Sierra Pacific Innovations, HGH, IRay Technology,... - July 20th, 2022
- From WBC to ANZ: Why are these NZX banking shares in news today? - Kalkine Media - July 20th, 2022
- Electro-Optical/Infrared (Eo/Ir) Systems Market to Witness Huge Growth by 2029 -Lockheed Martin Corporation, General Dynamics, L-3Harris Technologies,... - July 4th, 2022
- Positive Results from VISEN's Phase 3 Trial of Once-Weekly TransCon hGH in China Consistent with Ascendis Pharma's Phase 3 Height Trial -... - June 23rd, 2022
- Swole Is The Goal: ARod's Girlfriend Gets A Pump In On Their Italian Vacation - OutKick - June 23rd, 2022
- Heartland Group Holdings' (NZSE:HGH) earnings growth rate lags the 13% CAGR delivered to shareholders - Simply Wall St - June 14th, 2022
- Never Take This After Age 50, Warn Pharmacists Eat This Not That - Eat This, Not That - June 14th, 2022
- This Week in Local History June 15, 2022 The Review Archives 1972: WWF stars injured in highway crash 1922: Mystery of disappearing bridegroom... - June 14th, 2022
- Sleeping Tips for Runners and Why Rest Is So Important - runnersworld.com - June 14th, 2022
- Bubble Gut {or Palumboism} What, Why & How to Stop HGH Belly - May 16th, 2022
- Nominees Announced for 2022 Basie Awards - Celebration of High School Theatre - Atlantic Highlands Herald - May 3rd, 2022
- Healthy Month of Ramadan: Benefits of fasting - Scoop Empire - April 20th, 2022
- Jeff Bezos Not Taking HGH, Source - April 7th, 2022
- Heartland Group (ASX:HGH) bolsters executive team - The Market Herald - April 7th, 2022
- 24/7 Kiln shell temperature monitoring and Process Optimisation at LafargeHolcim Bouskoura plant, Morocco, using HGH thermography solutions - World... - April 7th, 2022
- Former UFC fighter Chael Sonnen being charged with 11 counts of battery over December incident in Las Vegas - ABC News - March 27th, 2022
- 10 benefits of Human Growth Hormone (HGH) therapy - January 23rd, 2022
- HGH Intrusion Detection and Identification At INTERSEC - Joint Forces - January 23rd, 2022
- Racing fit and over 40: Training secrets of the super-veterans - Cycling Weekly - January 23rd, 2022
- The SWIR market is expected to grow from USD 166 million in 2021 to USD 277 million by 2027; it is expected to grow at a CAGR of 8.9% - Yahoo Finance - January 23rd, 2022
- Sermorelin: A better approach to ... - PubMed Central (PMC) - January 8th, 2022
- Effect of human growth hormone therapy on penile ... - PubMed - January 8th, 2022
- HGH emergency department may temporarily close amid COVID-19 outbreak and staff shortage - The Review Newspaper - January 8th, 2022
- Year in Sports: The GOOD, the BAD, and the UGLY - Coast News - January 8th, 2022
- Couple's annual donations in support of the HGH Foundation reach $1 million - The Review Newspaper - December 26th, 2021
- HGH: Side Effects in Men and Women - Healthline - December 26th, 2021
- Nurse shortage the reason for temporary service reductions at HGH - The Review Newspaper - November 12th, 2021
- HGH and Sport celebrities: Why they use HRT - The Sports Bank - October 20th, 2021
- Outlook on the Protein Therapeutics Global Market to 2026 - by Product, Therapy Area, Function and Region - ResearchAndMarkets.com - Yahoo Finance - October 20th, 2021
- COVID-19 vaccination rates are higher across the St. Lawrence River, but opposition remains - North Country Public Radio - October 20th, 2021
- If we don't face vaccine facts, the pandemic will continue - The Review Newspaper - October 20th, 2021
- Ascendis Pharma A/S Announces US Commercial Launch of SKYTROFA (Lonapegsomatropin-tcgd), the First and Only FDA Approved Once-Weekly Treatment for... - October 20th, 2021
- Global Protein Therapeutics Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - Yahoo Finance - October 20th, 2021
- Keto might be more popular, but is intermittent fasting a better diet? Here's what to know - Courier Journal - October 20th, 2021
- Blessing Okagbare charged with use of two banned substances - AW - Athletics Weekly - October 9th, 2021
- Is SHIB Going to be the New DOGE? Could This Meme Coin be the Next Millionaire Maker? - Tech Times - October 9th, 2021
- Horizon Theatre Announces Return to Live and In-Person Theatre with SOUTHBOUND HALLOWEEN - Broadway World - October 9th, 2021
- Heartland Group Holdings' (NZSE:HGH) one-year earnings growth trails the respectable shareholder returns - Simply Wall St - September 5th, 2021
- NZME Limited (NZX: NZM) Half Year Results to 30 June 2021 - sharechat.co.nz - sharechat - August 24th, 2021